EMD-76963

Single-particle
3.2 Å
EMD-76963 Deposition: 29/04/2026
Map released: 08/07/2026
Last modified: 29/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-76963

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-13cm summary report (pdf.gz) Map-13cm FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

HAdV-C5 Hexon with coagulation factor II

EMD-76963

Single-particle
3.2 Å
EMD-76963 Deposition: 29/04/2026
Map released: 08/07/2026
Last modified: 29/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Human adenovirus 5, Homo sapiens
Sample: Purified Human adenovirus type 5 hexon trimer in complex with prothrombin (FII)
Fitted models: 13cm

Deposition Authors: Ma OX, Reddy VS
Structural requirements of blood factors binding to soluble hexon trimers with implications for adenovirus cell targeting and immune evasion.
Ma OX, Lu SC , Mudrick HE, Barry ME, French JB , Barry MA, Reddy VS
(2026) PLoS Pathog , 22 , e1014389 - e1014389
PUBMED: 42441716
DOI: doi:10.1371/journal.ppat.1014389
ISSN: 1553-7374